(DIR) Return Create A Forum - Home
       ---------------------------------------------------------
       MS Speaks
 (HTM) https://msspeaks.createaforum.com
       ---------------------------------------------------------
       *****************************************************
 (DIR) Return to: TECFIDERA (dimethyl fumarate, BG-12, Fumaderm)
       *****************************************************
       #Post#: 3000--------------------------------------------------
       (Abst.) PML in Tecfidera-treated MS patients
       By: agate Date: August 20, 2020, 2:33 pm
       ---------------------------------------------------------
       From PubMed (August 20, 2020)--"Progressive multifocal
       leucoencephalopathy in dimethyl fumarate-treated multiple
       sclerosis patients":
 (HTM) https://pubmed.ncbi.nlm.nih.gov/32808554/
       The researchers are affiliated with the Consortium of Multiple
       Sclerosis Centers (CMSC) and the University of Michigan.
       #Post#: 3839--------------------------------------------------
       PML outcomes in MS patients treated with dimethyl fumarate
       By: agate Date: November 14, 2022, 1:41 am
       ---------------------------------------------------------
       Some Biogen researchers have published a report on MS patients
       being treated with dimethyl fumarate who developed PML.
       From Multiple Sclerosis Journal (November 10,
       2022)--"Progressive multifocal leucoencephalopathy outcomes in
       patients with multiple sclerosis treated with dimethyl
       fumarate":
 (HTM) https://journals.sagepub.com/doi/full/10.1177/20552173221132469
       #Post#: 3957--------------------------------------------------
       Authors' correction to the previously cited article
       By: agate Date: March 8, 2023, 1:35 am
       ---------------------------------------------------------
       The authors of the article in the previous post in this thread
       have published a correction (Multiple Sclerosis Journal,
       February 27, 2023):
 (HTM) https://journals.sagepub.com/doi/full/10.1177/20552173231160312
       *****************************************************